Cue Biopharma, Inc. <CUE.O>: B. Riley Initiates Coverage With Buy Rating; Target Price $83
CUE•Related News
Progressive posts August net income of $951 million, down 22% y/y
PGR•
Karman director Stephen Twitty acquires $10,117.25 in common shares
KRMN•
Array Technologies Inc <ARRY.O>: UBS cuts target price to $5 from $10
ARRY•
SOS sells 19,000,000 shares in unregistered offering at US$ 0.18 each for US$ 3.42 million
SOS•
DraftKings Inc. <DKNG.O>: UBS cuts target price to $48 from $49
DKNG•